11 November 2016
The Late Medical Effects of Cancer Treatments – Royal College of Physicians
This one-day conference will focus on the medical late effects of cancer treatments in cancer survivors. Iron overload has been indicated in cancer survivors as a result of treatments and as such FerriScan may play a role in the monitoring and management of these patients.
Resonance Health’s Marketing Director, Melanie Baxter, and Research Consultant, Dr Susanna Katay-Davies (MD), will be attending the conference. It will provide the opportunity to discuss best practice and the role of FerriScan in this field.
For more information on the conference please click here…